Category: AHIP Letters

Striking down weak patents protects patients

In some cases, explosive drug prices are the result of drugmakers’ patent schemes that financially distress consumers and limit their treatment options. That is why a recent proposal to exempt pharmaceutical companies from a key consumer protection would leave families across the country even more hostage to egregious pharmaceutical prices. Continue reading

Posted in: AHIP Letters, Cost Alert

Don’t Mess with the IPR

When pharmaceutical companies artificially prolong drug patents to avoid competition from generics, consumers end up with fewer treatment options and higher costs. These latest patent abuses demonstrate the need for strong oversight of drugmakers’ monopoly pricing schemes. Continue reading

Posted in: AHIP Letters, Issue Alert

AHIP Requests Additional Time to Submit Exchange Applications

America’s Health Insurance Plans’ (AHIP) President and CEO Karen Ignagni today sent a letter to CMS urging the agency to extend the deadline for submitting applications for the federally facilitated exchange. Continue reading

Posted in: AHIP, AHIP Letters

AHIP Comment Letters on ACA Regulations

AHIP recently submitted comment letters on several proposed ACA regulations released by the U.S. Department of Health and Human Services (HHS). Continue reading

Posted in: ACA, AHIP, AHIP Letters

AHIP’s Letter to HHS on the Essential Health Benefits’ Bulletin

Earlier today, AHIP submitted a comment letter to HHS in response to the Essential Health Benefits Bulletin released on December 16, 2011. AHIP’s comments strongly emphasize the need to assure an affordable EHB benefit package that promotes access to high-quality and cost-effective care for patients and consumers. Continue reading

Posted in: ACA, AHIP, AHIP Letters, Issue Alert

Karen Ignagni Letter to the Editor (New York Times)

Karen Ignagni’s letter to the editor appeared in the New York Times, Saturday, December 9, 2011 – “Any comparison between Medicare Advantage and fee-for-service Medicare must acknowledge the fact that Medicare Advantage plans provide more and better benefits.” Continue reading

Posted in: AHIP Letters

AHIP Submits Comments to HHS on the Proposed Rule for Exchanges

AHIP submitted comments to HHS yesterday on the proposed rule for the establishment of health insurance exchanges. Continue reading

Posted in: ACA, AHIP, AHIP Letters, Issue Alert

The Latest on ACOs

Get the latest information on the ACO regulation and AHIP’s comment letters, an examination of private sector payment and delivery system reform initiatives, a new study on hospital market concentration and what employers have to say about anti-trust issues related to the ACO regulation. Continue reading

Posted in: ACA, AHIP, AHIP Letters, AHIP Studies and Reports, Issue Alert

AHIP’s Letters on the ACO Regulation

AHIP has submitted three letters to CMS, DOJ and the FTC on issues related to ACOs. Continue reading

Posted in: AHIP, AHIP Letters

Inside Health Policy: AHIP Says Proposed ACO Rule Should Build on Private Sector Work

Inside Health Policy reports that AHIP says ACO regulation should build off of what private health plans are doing already. Continue reading

Posted in: ACA, AHIP, AHIP Letters, In Case You Missed It, Issue Alert